SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Profiteer who wrote (3062)	7/12/1998 7:45:00 PM
From: Prospector	of 5402

Sanguine's advisory Board... Kevin Tremper MD Dr temper is the Chairman of the Department of Anesthesiology at the University of Michigan and a leader in the field of synthetic blood research. His published articles on this subject include "Hemodynimic and Oxygen Transport Effects of a Perfluorochemical Blood Substitute, Fluosol DA-20" 8 Critical Care Medicine 738 1980 , rationale for the Clinical Studies of Anemia Treated with the Perfluorochemical Emulsion Fluosol, Advances in Blood Subtitute Research International Symposium, San Francisco, September 1982.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next